Launch week offerEnds in00h00m00s

annual Promonthly Pro

Juan Iovanna

Has grant

DRCE

INSERM

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Cell Biology Cell Biology professors in France

Recent Grants

Grant: Close

Role of the stress protein Nupr1 in pancreatic adenocarcinoma development

Open Date: 2012-12-27

Close Date: 2015-12-27

Grant: Close

Pancreatic Cancer in PACA

Open Date: 2007-12-14

Close Date: 2011-02-13

Articles (26)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Jean-Emmanuel Sarry

Principal Investigator

INSERM Délégation régionale Midi-Pyrenees Limousin

FRANCE

View details

Marisa Nishio

Assistant Professor

Kyoto University

JAPAN

View details

Ling Peng

Research Director

CNRS

FRANCE

View details

Gwen Lomberk

Professor

Medical College of Wisconsin

UNITED STATES

View details

Nelson Dusetti

Cancer Research Center of Marseille

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

FRANCE

View details

Teodora‐Adriana Perles‐Barbacaru

Associate Professor

Aix-Marseille University

FRANCE

View details

Palma Rocchi

INSERM

FRANCE

View details

Karol Nowicki-Osuch

Junior Group Leader

Deutsches Krebsforschungszentrum

GERMANY

View details

Ryuji Hamamoto

Division Chief

JAPAN

View details

Philippe Soubeyran

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juan Iovanna

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (26)

Poor-prognosis cancers: from resignation to revolution

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries

Single-cell transcriptomic profiling of patient-derived pancreatic ductal adenocarcinoma primary cell cultures

A comprehensive proteomic dataset of secretomes from primary pancreatic cancer cell cultures

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

Self-assembling dendrimer nanodrug formulations for decreased hERG- related toxicity and enhanced therapeutic efficacy

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures

Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models

Correction to “Discovery of Novel Arylethynyltriazole Ribonucleosides with Selective and Effective Antiviral and Antiproliferative Activity”

Correction to “Novel Triazole Ribonucleoside Down-Regulates Heat Shock Protein 27 and Induces Potent Anticancer Activity on Drug-Resistant Pancreatic Cancer”

Understanding the heterogeneity of pancreatic ductal adenocarcinoma

Oncogenic stress response mechanisms as new therapeutic targets in cancer treatment: A review

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer

Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine response

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

Targeting REG3β limits pancreatic ductal adenocarcinoma progression through CTGF downregulation

NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner

Targeting intrinsically disordered proteins involved in cancer

Novel triazole nucleoside analogues promote anticancer activity via both apoptosis and autophagy

Collaborators (10)

Jean-Emmanuel Sarry

Marisa Nishio

Ling Peng

Gwen Lomberk

Nelson Dusetti

Teodora‐Adriana Perles‐Barbacaru

Palma Rocchi

Karol Nowicki-Osuch

Ryuji Hamamoto

Philippe Soubeyran

Make your next move.